ID   SODE_HUMAN              Reviewed;         240 AA.
AC   P08294; Q5U781; Q6FHA2;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   10-MAY-2017, entry version 186.
DE   RecName: Full=Extracellular superoxide dismutase [Cu-Zn];
DE            Short=EC-SOD;
DE            EC=1.15.1.1;
DE   Flags: Precursor;
GN   Name=SOD3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANT
RP   THR-58.
RX   PubMed=3476950; DOI=10.1073/pnas.84.18.6340;
RA   Hjalmarsson K., Marklund S.L., Engstroem A., Edlund T.;
RT   "Isolation and sequence of complementary DNA encoding human
RT   extracellular superoxide dismutase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6340-6344(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-58.
RC   TISSUE=Blood;
RX   PubMed=7959763; DOI=10.1006/geno.1994.1357;
RA   Folz R.J., Crapo J.D.;
RT   "Extracellular superoxide dismutase (SOD3): tissue-specific
RT   expression, genomic characterization, and computer-assisted sequence
RT   analysis of the human EC SOD gene.";
RL   Genomics 22:162-171(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-58.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-58; THR-91 AND
RP   GLY-231.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-58.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   GLYCATION AT LYS-229 AND LYS-230.
RX   PubMed=1505778; DOI=10.1016/0891-5849(92)90016-A;
RA   Adachi T., Ohta H., Hayashi K., Hirano K., Marklund S.L.;
RT   "The site of nonenzymic glycation of human extracellular-superoxide
RT   dismutase in vitro.";
RL   Free Radic. Biol. Med. 13:205-210(1992).
RN   [7]
RP   REVIEW.
RX   PubMed=16087389; DOI=10.1016/j.biocel.2005.06.012;
RA   Nozik-Grayck E., Suliman H.B., Piantadosi C.A.;
RT   "Extracellular superoxide dismutase.";
RL   Int. J. Biochem. Cell Biol. 37:2466-2471(2005).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-107.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-107.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 19-240, SUBUNIT,
RP   METAL-BINDING SITES, AND DISULFIDE BONDS.
RX   PubMed=19289127; DOI=10.1016/j.jmb.2009.03.026;
RA   Antonyuk S.V., Strange R.W., Marklund S.L., Hasnain S.S.;
RT   "The structure of human extracellular copper-zinc superoxide dismutase
RT   at 1.7 A resolution: insights into heparin and collagen binding.";
RL   J. Mol. Biol. 388:310-326(2009).
RN   [11]
RP   VARIANT GLY-231.
RX   PubMed=8034674;
RA   Sandstrom J., Nilsson P., Karlsson K., Marklund S.L.;
RT   "10-fold increase in human plasma extracellular superoxide dismutase
RT   content caused by a mutation in heparin-binding domain.";
RL   J. Biol. Chem. 269:19163-19166(1994).
RN   [12]
RP   VARIANT GLY-231.
RX   PubMed=7662997; DOI=10.1007/BF01883574;
RA   Yamada H., Yamada Y., Adachi T., Goto H., Ogasawara N., Futenma A.,
RA   Kitano M., Hirano K., Kato K.;
RT   "Molecular analysis of extracellular-superoxide dismutase gene
RT   associated with high level in serum.";
RL   Jpn. J. Hum. Genet. 40:177-184(1995).
RN   [13]
RP   VARIANT GLY-231.
RX   PubMed=8546689; DOI=10.1042/bj3130235;
RA   Adachi T., Yamada H., Yamada Y., Morihara N., Yamazaki N.,
RA   Murakami T., Futenma A., Kato K., Hirano K.;
RT   "Substitution of glycine for arginine-213 in extracellular-superoxide
RT   dismutase impairs affinity for heparin and endothelial cell surface.";
RL   Biochem. J. 313:235-239(1996).
RN   [14]
RP   VARIANT GLY-231.
RX   PubMed=8864862; DOI=10.1093/oxfordjournals.jbchem.a021383;
RA   Adachi T., Morihara N., Yamazaki N., Yamada H., Futenma A., Kato K.,
RA   Hirano K.;
RT   "An arginine-213 to glycine mutation in human extracellular-superoxide
RT   dismutase reduces susceptibility to trypsin-like proteinases.";
RL   J. Biochem. 120:184-188(1996).
CC   -!- FUNCTION: Protect the extracellular space from toxic effect of
CC       reactive oxygen intermediates by converting superoxide radicals
CC       into hydrogen peroxide and oxygen.
CC   -!- CATALYTIC ACTIVITY: 2 superoxide + 2 H(+) = O(2) + H(2)O(2).
CC   -!- COFACTOR:
CC       Name=Cu cation; Xref=ChEBI:CHEBI:23378; Evidence={ECO:0000250};
CC       Note=Binds 1 copper ion per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:19289127}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10195782, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space. Note=99% of
CC       EC-SOD is anchored to heparan sulfate proteoglycans in the tissue
CC       interstitium, and 1% is located in the vasculature in equilibrium
CC       between the plasma and the endothelium.
CC   -!- TISSUE SPECIFICITY: Expressed in blood vessels, heart, lung,
CC       kidney and placenta. Major SOD isoenzyme in extracellular fluids
CC       such as plasma, lymph and synovial fluid.
CC   -!- POLYMORPHISM: The variant Gly-231 which is found in about 2.2% of
CC       individual displays a 10-fold increased plasma EC-SOD content due
CC       to reduced heparin-binding affinity and thus the impairment of its
CC       binding ability to endothelial cell surface.
CC       {ECO:0000269|PubMed:7662997, ECO:0000269|PubMed:8034674,
CC       ECO:0000269|PubMed:8546689}.
CC   -!- SIMILARITY: Belongs to the Cu-Zn superoxide dismutase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/sod3/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Superoxide dismutase entry;
CC       URL="https://en.wikipedia.org/wiki/Superoxide_dismutase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02947; AAA66000.1; -; mRNA.
DR   EMBL; U10116; AAA62278.1; -; Genomic_DNA.
DR   EMBL; CR541853; CAG46651.1; -; mRNA.
DR   EMBL; AY787834; AAV40827.1; -; Genomic_DNA.
DR   EMBL; BC014418; AAH14418.1; -; mRNA.
DR   CCDS; CCDS3430.1; -.
DR   PIR; A28301; DSHUEC.
DR   RefSeq; NP_003093.2; NM_003102.2.
DR   UniGene; Hs.2420; -.
DR   PDB; 2JLP; X-ray; 1.70 A; A/B/C/D=19-240.
DR   PDBsum; 2JLP; -.
DR   ProteinModelPortal; P08294; -.
DR   SMR; P08294; -.
DR   BioGrid; 112532; 1.
DR   IntAct; P08294; 8.
DR   STRING; 9606.ENSP00000371554; -.
DR   BindingDB; P08294; -.
DR   ChEMBL; CHEMBL2069159; -.
DR   iPTMnet; P08294; -.
DR   PhosphoSitePlus; P08294; -.
DR   BioMuta; SOD3; -.
DR   DMDM; 108885292; -.
DR   EPD; P08294; -.
DR   MaxQB; P08294; -.
DR   PaxDb; P08294; -.
DR   PeptideAtlas; P08294; -.
DR   PRIDE; P08294; -.
DR   DNASU; 6649; -.
DR   Ensembl; ENST00000382120; ENSP00000371554; ENSG00000109610.
DR   GeneID; 6649; -.
DR   KEGG; hsa:6649; -.
DR   UCSC; uc003gqz.4; human.
DR   CTD; 6649; -.
DR   DisGeNET; 6649; -.
DR   GeneCards; SOD3; -.
DR   HGNC; HGNC:11181; SOD3.
DR   HPA; HPA042110; -.
DR   MIM; 185490; gene.
DR   neXtProt; NX_P08294; -.
DR   OpenTargets; ENSG00000109610; -.
DR   PharmGKB; PA36018; -.
DR   eggNOG; KOG0441; Eukaryota.
DR   eggNOG; COG2032; LUCA.
DR   GeneTree; ENSGT00530000063226; -.
DR   HOGENOM; HOG000263447; -.
DR   HOVERGEN; HBG000062; -.
DR   InParanoid; P08294; -.
DR   KO; K16627; -.
DR   OMA; HPRHPGD; -.
DR   OrthoDB; EOG091G13ID; -.
DR   PhylomeDB; P08294; -.
DR   TreeFam; TF105133; -.
DR   BioCyc; MetaCyc:HS03242-MONOMER; -.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   EvolutionaryTrace; P08294; -.
DR   GeneWiki; SOD3; -.
DR   GenomeRNAi; 6649; -.
DR   PMAP-CutDB; P08294; -.
DR   PRO; PR:P08294; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109610; -.
DR   CleanEx; HS_SOD3; -.
DR   ExpressionAtlas; P08294; baseline and differential.
DR   Genevisible; P08294; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005507; F:copper ion binding; IBA:GO_Central.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004784; F:superoxide dismutase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IBA:GO_Central.
DR   GO; GO:0019430; P:removal of superoxide radicals; IBA:GO_Central.
DR   GO; GO:0046688; P:response to copper ion; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0000302; P:response to reactive oxygen species; TAS:Reactome.
DR   CDD; cd00305; Cu-Zn_Superoxide_Dismutase; 1.
DR   Gene3D; 2.60.40.200; -; 1.
DR   InterPro; IPR018152; SOD_Cu/Zn_BS.
DR   InterPro; IPR001424; SOD_Cu_Zn_dom.
DR   Pfam; PF00080; Sod_Cu; 1.
DR   PRINTS; PR00068; CUZNDISMTASE.
DR   SUPFAM; SSF49329; SSF49329; 1.
DR   PROSITE; PS00087; SOD_CU_ZN_1; 1.
DR   PROSITE; PS00332; SOD_CU_ZN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antioxidant; Complete proteome; Copper;
KW   Direct protein sequencing; Disulfide bond; Glycation; Glycoprotein;
KW   Heparin-binding; Metal-binding; Oxidoreductase; Polymorphism;
KW   Reference proteome; Secreted; Signal; Zinc.
FT   SIGNAL        1     18
FT   CHAIN        19    240       Extracellular superoxide dismutase [Cu-
FT                                Zn].
FT                                /FTId=PRO_0000032855.
FT   METAL       114    114       Copper; catalytic.
FT   METAL       116    116       Copper; catalytic.
FT   METAL       131    131       Copper; catalytic.
FT   METAL       131    131       Zinc; structural.
FT   METAL       139    139       Zinc; structural.
FT   METAL       142    142       Zinc; structural.
FT   METAL       145    145       Zinc; structural.
FT   METAL       181    181       Copper; catalytic.
FT   SITE         41     41       Not glycated.
FT   SITE         92     92       Not glycated.
FT   SITE        238    238       Not glycated.
FT   CARBOHYD    107    107       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    229    229       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    230    230       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   DISULFID     63    208       {ECO:0000269|PubMed:19289127}.
FT   DISULFID    125    207       {ECO:0000269|PubMed:19289127}.
FT   VARIANT      58     58       A -> T (in dbSNP:rs2536512).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:3476950,
FT                                ECO:0000269|PubMed:7959763,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020776.
FT   VARIANT      91     91       A -> T (in dbSNP:rs17879876).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020777.
FT   VARIANT     231    231       R -> G (in dbSNP:rs1799895).
FT                                {ECO:0000269|PubMed:7662997,
FT                                ECO:0000269|PubMed:8034674,
FT                                ECO:0000269|PubMed:8546689,
FT                                ECO:0000269|PubMed:8864862,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014705.
FT   STRAND       59     67       {ECO:0000244|PDB:2JLP}.
FT   STRAND       79     88       {ECO:0000244|PDB:2JLP}.
FT   STRAND       93    100       {ECO:0000244|PDB:2JLP}.
FT   STRAND      104    117       {ECO:0000244|PDB:2JLP}.
FT   HELIX       124    128       {ECO:0000244|PDB:2JLP}.
FT   STRAND      145    152       {ECO:0000244|PDB:2JLP}.
FT   STRAND      155    164       {ECO:0000244|PDB:2JLP}.
FT   STRAND      166    169       {ECO:0000244|PDB:2JLP}.
FT   STRAND      176    183       {ECO:0000244|PDB:2JLP}.
FT   STRAND      190    192       {ECO:0000244|PDB:2JLP}.
FT   HELIX       195    198       {ECO:0000244|PDB:2JLP}.
FT   STRAND      204    209       {ECO:0000244|PDB:2JLP}.
FT   HELIX       216    222       {ECO:0000244|PDB:2JLP}.
SQ   SEQUENCE   240 AA;  25851 MW;  585B8DEBFC506CF4 CRC64;
     MLALLCSCLL LAAGASDAWT GEDSAEPNSD SAEWIRDMYA KVTEIWQEVM QRRDDDGALH
     AACQVQPSAT LDAAQPRVTG VVLFRQLAPR AKLDAFFALE GFPTEPNSSS RAIHVHQFGD
     LSQGCESTGP HYNPLAVPHP QHPGDFGNFA VRDGSLWRYR AGLAASLAGP HSIVGRAVVV
     HAGEDDLGRG GNQASVENGN AGRRLACCVV GVCGPGLWER QAREHSERKK RRRESECKAA
//
